Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TrueBlue (TBI) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for TrueBlue (TBI) over the last 17 years, with Q3 2025 value amounting to $29.9 million.

  • TrueBlue's Shares Outstanding (Diluted Average) fell 160.61% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year decrease of 160.61%. This contributed to the annual value of $30.2 million for FY2024, which is 364.02% down from last year.
  • Latest data reveals that TrueBlue reported Shares Outstanding (Diluted Average) of $29.9 million as of Q3 2025, which was down 160.61% from $29.9 million recorded in Q2 2025.
  • In the past 5 years, TrueBlue's Shares Outstanding (Diluted Average) registered a high of $35.5 million during Q3 2021, and its lowest value of $29.7 million during Q1 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $31.6 million (2023), whereas its average is $32.4 million.
  • Per our database at Business Quant, TrueBlue's Shares Outstanding (Diluted Average) grew by 19.51% in 2021 and then tumbled by 651.92% in 2023.
  • Over the past 5 years, TrueBlue's Shares Outstanding (Diluted Average) (Quarter) stood at $35.4 million in 2021, then decreased by 5.61% to $33.4 million in 2022, then fell by 6.37% to $31.3 million in 2023, then fell by 3.64% to $30.2 million in 2024, then dropped by 0.93% to $29.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $29.9 million for Q3 2025, versus $29.9 million for Q2 2025 and $29.7 million for Q1 2025.